$HNSA #Hansa Biopharma AB Hansa Biopharma - Imlifidase set for oral explanation: CHMP agenda requires oral explanation Adds some uncertainty despite promising odds We expect a positive market reaction https://t.co/5XyDCiOIDB #equity #stocks https://t.co/6kvU8Ax2KE